News Article | May 9, 2017
LIVONIA, Mich., May 09, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including dyslipidemia and NASH, today announced financial results for the first quarter ended March 31, 2017, and provided a corporate update. “The first quarter was a very productive start to 2017 for Gemphire, highlighted by continued progress in developing gemcabene, our first-in-class, once-daily, oral drug candidate for the treatment of dyslipidemia and NALFD/NASH,” said Mina Sooch, President and CEO of Gemphire. “We are currently conducting three late stage clinical trials for gemcabene: our COBALT-1 trial for HoFH patients; our ROYAL-1 trial for hypercholesterolemia, including HeFH and ASCVD patients on maximally tolerated statins; and, our INDIGO-1 trial for SHTG patients. During the quarter, we completed enrollment of both our COBALT-1 and ROYAL-1 trials, on or ahead of schedule, and enrolled our first patients in our INDIGO-1 trial. We expect to report top line data from our COBALT-1 and ROYAL-1 studies in June and third quarter 2017, respectively. The third trial, INDIGO-1, is currently enrolling and we expect top line data in early 2018. Based on gemcabene’s lipid-lowering and anti-inflammatory mechanism of action, and on the strength of positive preclinical data we announced during the first quarter, we also have plans to launch a Phase 2 clinical development program in NASH this year.” Research and development expenses for the three months ended March 31, 2017 were $5.3 million compared to $1.2 million for the three months ended March 31, 2016. The increase was primarily attributable to increased clinical trial activities encompassing three separate Phase 2b clinical trials on-going in the current year period versus no active clinical studies in the prior year period. Research and development expenses included $0.3 million in share‑based compensation expense during the three months ended March 31, 2017. There was no share‑based compensation expense included in research and development expense during the three months ended March 31, 2016. General and administrative expenses for the three months ended March 31, 2017 were $2.2 million compared to $1.1 million for the three months ended March 31, 2016. Increased infrastructure costs to support the clinical trials and public company requirements, focused primarily in increased personnel costs, including share-based compensation expense, and professional services were the primary drivers of the increase over the prior year period. General and administrative expenses included $0.6 million and $0.1 in share‑based compensation expense during the three months ended March 31, 2017 and 2016, respectively. Net loss attributable to common stockholders for the three months ended March 31, 2017 was $7.5 million or ($0.79) per basic and diluted share, compared to $2.3 million, or ($0.65) per basic and diluted share in the same period of 2016. Cash and cash equivalents at March 31, 2017 totaled $29.3 million compared to $24.0 million at December 31, 2016. On March 15, 2017, the Company closed its previously announced private placement and received gross proceeds of approximately $12.5 million. As we previously guided, management expects full year operating expenses and cash used in operating activities to be approximately double 2016 levels, primarily in research and development as we fund our ongoing clinical trials, and to be more heavily weighted in the first two quarters of 2017, aligned with the activity levels of ongoing trials. Accordingly, we expect second quarter 2017 operating expenses and cash used in operations to continue to be substantially above comparable prior period levels, and to be above first quarter 2017 levels. In addition, management expects quarterly non-cash, share-based compensation levels to trend at or above first quarter levels through 2017. Based on the Company’s current operating plans, management believes existing cash, including the net proceeds from the private placement, is sufficient to fund operations through completion of all three of the ongoing dyslipidemia trials, as well as the new NASH Phase 2 trial expected to be complete in the second half of 2018. In January 2017, Gemphire announced plans to initiate clinical development of gemcabene in NASH. The decision to rapidly advance in NASH was based on multiple completed clinical trials in which gemcabene has shown the ability to lower biomarkers for blood lipids such as triglycerides (fat) and inflammation, both of which are relevant in the pathogenesis of NASH along with positive results from the recent preclinical NASH model. In a preclinical study conducted in diabetic mice, a hepatoprotective effect preventing liver disease progression was observed with gemcabene, in contrast to the control group. Specifically, gemcabene treatment resulted in a significant lowering of the liver NAFLD activity score (NAS), a composite measure of fatty liver disease comprised of measures of steatosis, inflammation, and hepatocyte ballooning. Progression of liver fibrosis was also significantly reduced with gemcabene treatment. The data from the preclinical NASH study has been submitted for publication in a peer review journal. Following the acceptance of gemcabene’s IND in NASH, Gemphire plans to initiate the Phase 2 AZURE-1 trial for NASH in the second half of 2017. The Company believes gemcabene’s ability to lower both triglycerides and inflammation while also reducing the progression of fibrosis through multiple mechanisms, may represent a differentiated treatment option for NASH patients. Also in January 2017, the Company announced positive interim data on the LDL-C primary endpoint from the ongoing open label COBALT-1 trial. COBALT-1 is evaluating gemcabene in HoFH patients. The results from two genetically-confirmed HoFH patients through 8 weeks of treatment showed that gemcabene 600 mg decreased mean LDL-C by 28% on top of maximum statin and/or ezetimibe. No SAEs have been reported, where reported AEs have been mild to moderate and are consistent with previously completed studies. HoFH is an extremely rare disease, and the Company believes the total number of subjects in its trial will be sufficient to support advancement into Phase 3. In March, the Company announced the results of a Phase 2 trial that investigated insulin sensitization and LDL-C lowering by gemcabene in non-diabetic, obese patients. The results were featured in a poster presentation at the American College of Cardiology 66th Annual Scientific Session in Washington, D.C. Fifty-three subjects entered the trial, ranging in age from 26 to 63 years, BMI 30 to 40kg/m2, and fasting glucose <126mg/dL, entered the study. Following a 2-week screening phase, subjects were randomized to receive either 900 mg gemcabene or placebo on Day 2 through Week 4. Gemcabene was associated with a doubling of 13% mean increase in glucose disposal rate (GDR) compared to a 6.8% increase for placebo. Although statistical significance was not observed in the pre-specified analysis, a post-hoc analysis more applicable to the size of this study showed a statistically significant change from baseline to Day 29 in GDR for gemcabene 900 mg (p<0.0178) versus a non-significant effect for placebo. In addition, gemcabene 900 mg lowered LDL-C by 40% (p<0.0001) and plasma total cholesterol by 27% (p<0.0001) consistent with past results in hypercholesterolemia subjects. Gemcabene was generally well-tolerated. There were no deaths, SAEs, or withdrawals due to adverse events during the study. In May, the Company presented a Poster at the Arteriosclerosis, Thrombosis and Vascular Biology | Peripheral Vascular Disease (ATVB|PVD) 2017 Scientific Sessions confirming the pleiotropic effects with multiple mechanisms of action for gemcabene in in vitro models. Across the various models, gemcabene was shown to lower hepatic gene biomarkers for lipid regulation (ACC1, APOC-III, Sulfatase 2,ADH4, and HMG-CoA Synthase 2) and inflammation (CRP, TNF-α, MCP-1, CCR2, CCR5, NF-Kβ, MIP-1β) as well as plasma biomarkers (LDL-C, TG, hsCRP). About Gemcabene Gemphire’s product candidate, gemcabene (CI-1027), is a first-in-class, once-daily, oral therapy that may be suitable for patients who are unable to achieve normal levels of LDL-C or triglycerides with currently approved therapies, primarily statins. Gemcabene's mechanism of action is designed to enhance the clearance of very low-density lipoproteins (VLDLs) in the plasma and inhibition of the production of cholesterol and triglycerides in the liver. The combined effect for these mechanisms has been clinically observed to result in a reduction of plasma VLDL-C, LDL-C, and triglycerides. In addition, gemcabene has been shown to markedly lower C-reactive protein and improve insulin sensitization. Gemcabene is liver-directed and reduces apoC-III mRNA and plasma levels. Gemcabene also reduces acetyl-CoA carboxylase (ACC1) and CCR2/CCR5 receptor mRNA levels, which may have applications in non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD). Gemcabene has demonstrated proof of concept efficacy in the STAM™ model for NASH developed at SMC Laboratories in Tokyo, Japan. Gemcabene has been tested as monotherapy and in combination with statins and other drugs in 895 subjects across 18 Phase 1 and Phase 2 clinical trials and has demonstrated promising evidence of efficacy, safety and tolerability. About Gemphire Gemphire is a clinical-stage biopharmaceutical company that is committed to helping patients with cardiometabolic disorders, including dyslipidemia and NASH. We are focused on providing new treatment options for cardiometabolic diseases through our complementary, convenient, cost-effective product candidate gemcabene as add-on to the standard of care especially statins that will benefit patients, physicians, and payors. Gemphire has initiated 3 clinical trials for homozygous familial hypercholesterolemia (HoFH), heterozygous familial hypercholesterolemia (HeFH)/atherosclerotic cardiovascular disease (ASCVD), and severe hypertriglyceridemia (SHTG) under NCT02722408, NCT02634151, and NCT02944383, respectively with a fourth planned trial in NASH to initiate in second half of 2017. Please visit www.gemphire.com for more information. Forward Looking Statements Any statements in this press release about Gemphire’s future expectations, plans and prospects, including statements about Gemphire’s financial prospects, future operations and sufficiency of funds for future operations, clinical development of Gemphire’s product candidate, expectations regarding future clinical trials and future expectations and plans and prospects for Gemphire, expectations regarding operating expenses and cash used in operations, and other statements containing the words "believes," "anticipates," "estimates," "expects," "intends," "plans," "predicts," "projects," "targets," "may," "potential," "will," "would," "could," "should," "continue," “scheduled” and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the success and timing of Gemphire’s regulatory submissions and pre-clinical and clinical trials; regulatory requirements or developments; changes to Gemphire’s clinical trial designs and regulatory pathways; changes in Gemphire’s capital resource requirements; Gemphire’s ability to obtain additional financing; Gemphire’s ability to successfully market and distribute its product candidate, if approved; Gemphire’s ability to obtain and maintain its intellectual property protection; and other factors discussed in the "Risk Factors" section of Gemphire’s Annual Report on Form 10-K for the year ended December 31, 2016, and in other filings Gemphire makes with the SEC from time to time. In addition, the forward-looking statements included in this press release represent Gemphire’s views as of the date hereof. Gemphire anticipates that subsequent events and developments will cause Gemphire’s views to change. However, while Gemphire may elect to update these forward-looking statements at some point in the future, Gemphire specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Gemphire’s views as of any date subsequent to the date hereof.
News Article | May 8, 2017
TORONTO, ONTARIO--(Marketwired - May 8, 2017) - Sulliden Mining Capital Inc. (TSX:SMC) announces a non-brokered private placement financing of up to 5,000,000 units at a price of $0.25 per unit for proceeds to the company of approximately $1,250,000. Each unit will be comprised of one common share and one share purchase warrant, with each warrant entitling the holder to acquire one common share at a price of $0.35 at any time within the two years following closing. Sulliden intends to use the proceeds for the advancement of the Trolius Gold project, further investment opportunities and general working capital purposes. Closing is expected to occur on or before May 22, 2017, and is subject to the receipt of regulatory approvals, including the approval of the Toronto Stock Exchange. The securities issued on the financing will be subject to resale restrictions for a period of four months plus one day from the closing date. Sulliden Mining Capital is a venture capital company focused on acquiring and advancing brownfield, development-stage and early production-stage mining projects in the Americas. On behalf of the Board This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking information includes, without limitation, the proposed use of proceeds and the size of the financing. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including risks inherent in the mining industry and risks described in the public disclosure of the Company which is available under the profile of the Company on SEDAR at www.sedar.com and on the Company's website at www.sulliden.com. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
News Article | May 11, 2017
LONDON, May 11, 2017 /PRNewswire/ -- In a new publication titled "Soft Magnetic Materials Market: Global Industry Analysis and Forecast, 2016–2026," Persistence Market Research provides a comprehensive study of the global soft magnetic materials market. While inspecting this market, the analysts have observed that companies are looking to capitalize on market opportunities in the APEJ region. The researchers have further observed that factors such as a cheap labor force, the growing automotive industry and a vast electrical and electronics hub make the APEJ region quite important for manufacturers to increase their sales revenue. The overall market approach has been studied and the expert team of analysts have come to a conclusion that soft magnetic materials manufacturers work closely to cater to increasing demand for lightweight and high performance materials. Most of the companies are vertically integrated across the supply chain. Apart from this, the researchers have felt a need to target Fe amorphous and nano crystalline materials as they are technically advanced materials that are increasingly used in high end applications. Download the full report: https://www.reportbuyer.com/product/4895299/ Report Description The value chain analysis of the global soft magnetic materials market comprises soft magnetic materials manufacturers, component manufacturers and end users. The report begins with the market definition. The market dynamics section includes Persistence Market Research's analysis of key trends, drivers, restraints, opportunities and macro-economic factors influencing the development of the global soft magnetic materials market. The report analyzes the global soft magnetic materials market on the basis of material type, application and region and presents a forecast by value for the next 10 years. The global soft magnetic materials market has been further analyzed in terms of basis point share (BPS) to understand individual segments' relative contributions to market growth. This detailed level of information is important for identifying various key trends in the global soft magnetic materials market. A competitive landscape has been included in the last section of the report to provide a dashboard view of key companies operating in the global soft magnetic materials market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the global soft magnetic materials market and the potential players. This section also includes market strategies and SWOT analysis of the main players operational in the global soft magnetic materials market. Detailed profiles of soft magnetic materials manufacturers are also included in the scope of the report to evaluate their long- and short-term strategies. Global Soft Magnetic Materials Market: Segmentation By Material Type SMC Pure Iron/Iron Powder Silicon Ferrite Supermalloy Permalloy Soft Ferrite Fe Amorphous Nano Crystalline By Application Transformers Portable Transmission Distribution Motors 1 hp-100hp 101 hp-200 hp 201hp-1000hp Above 1000hp Inductors Generators By Region North America Latin America Western Europe Eastern Europe Japan APEJ Middle East and Africa Research Methodology Download the full report: https://www.reportbuyer.com/product/4895299/ About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers http://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: email@example.com Tel: +44 208 816 85 48 Website: www.reportbuyer.com To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-market-study-on-soft-magnetic-materials-western-europe-projected-to-gain-more-than-15-market-value-share-by-2026-end-300456314.html
News Article | May 14, 2017
Sales Management Consulting LLC Has Renewed Their Agreement to Exclusively Represent DPTechnics in North America Sharon, MA, May 14, 2017 --( Based in Belgium, DPTechnics offers turnkey design, development and manufacturing services to add IoT (Internet of Things) connectivity to unconnected control systems. The company manufacturers the DPT-Board, a CE/FCC compliant IoT-modem, designed for maximum reliability and 24/7 operation. Offering a large number of communication buses like I²C, SPI, UART, USB, Ethernet, WiFi, the DPT-Board IoT-modem can easily add secure IoT connectivity to existing OEM control systems. DPTechnics has developed BlueCherry, a unique Internet-of-Things platform, for secure, rapid, and cost effective development and deployment of IoT devices. Using BlueCherry, product manufacturer can securely access their IoT enabled devices worldwide. BlueCherry runs entirely on any browser, so it can be accessed with any web-enabled device with any operating system. DPTechnics optimizes ROI and shortens the time to market for IoT connected OEM product developers, by offering a single source for firmware development, IoT connectivity, hardware production and software development. Some examples of the systems that DPTechnics have developed for clients include: IoT-connected and controls of swimming pools, hydrotherapy spas, saunas, steam rooms and virtually any type of wellness accommodation. The Zora robot is a humanoid robot (based on the NAO robot from Softbank Robotics) for use with the elderly in residential care, in schools and hospitals. DPTechnics developed the WiFi connectivity system. HVAC systems, for industrial cooling applications. The DPTechnics based system monitors and sends out warnings, alarms and weekly reports to the owners of the installations. For more information and to talk about your goals for an IoT connected system, please contact SMC LLC at firstname.lastname@example.org. Sharon, MA, May 14, 2017 --( PR.com )-- Seth Frielich, CEO of Sales Management Consulting LLC is pleased to announce that SMC LLC has renewed their agreement to exclusively represent DPTechnics in North America.Based in Belgium, DPTechnics offers turnkey design, development and manufacturing services to add IoT (Internet of Things) connectivity to unconnected control systems. The company manufacturers the DPT-Board, a CE/FCC compliant IoT-modem, designed for maximum reliability and 24/7 operation. Offering a large number of communication buses like I²C, SPI, UART, USB, Ethernet, WiFi, the DPT-Board IoT-modem can easily add secure IoT connectivity to existing OEM control systems.DPTechnics has developed BlueCherry, a unique Internet-of-Things platform, for secure, rapid, and cost effective development and deployment of IoT devices. Using BlueCherry, product manufacturer can securely access their IoT enabled devices worldwide. BlueCherry runs entirely on any browser, so it can be accessed with any web-enabled device with any operating system.DPTechnics optimizes ROI and shortens the time to market for IoT connected OEM product developers, by offering a single source for firmware development, IoT connectivity, hardware production and software development.Some examples of the systems that DPTechnics have developed for clients include:IoT-connected and controls of swimming pools, hydrotherapy spas, saunas, steam rooms and virtually any type of wellness accommodation.The Zora robot is a humanoid robot (based on the NAO robot from Softbank Robotics) for use with the elderly in residential care, in schools and hospitals. DPTechnics developed the WiFi connectivity system.HVAC systems, for industrial cooling applications. The DPTechnics based system monitors and sends out warnings, alarms and weekly reports to the owners of the installations.For more information and to talk about your goals for an IoT connected system, please contact SMC LLC at email@example.com. Click here to view the list of recent Press Releases from Sales Management Consulting LLC
News Article | May 12, 2017
Visible in the southern night sky, the LMC and SMC are dwarf galaxies that orbit our home galaxy and lie at a distance of 160 and 200 thousand light-years from Earth respectively, "There were hints that this magnetic field might exist, but no one had observed it until now," says Jane Kaczmarek, a PhD student in the School of Physics, University of Sydney, and lead author of the paper describing the finding. Such cosmic magnetic fields can only be detected indirectly, and this detection was made by observing the radio signals from hundreds of very distant galaxies that lie beyond the LMC and SMC. The observations were made with the Australia Telescope Compact Array radio telescope at the Paul Wild Observatory in New South Wales, Australia. "The radio emission from the distant galaxies served as background 'flashlights' that shine through the Bridge," says Kaczmarek. "Its magnetic field then changes the polarization of the radio signal. How the polarized light is changed tells us about the intervening magnetic field." A radio signal, like a light wave, oscillates or vibrates in a single direction or plane; for example, waves on the surface of a pond move up and down. When a radio signal passes through a magnetic field, the plane is rotated. This phenomenon is known as Faraday Rotation and it allows astronomers to measure the strength and the polarity—or direction—of the field. The observation of the magnetic field, which is one millionth the strength of the Earth's, may provide insight into whether it was generated from within the Bridge after the structure formed, or was "ripped" from the dwarf galaxies when they interacted and formed the structure. "In general, we don't know how such vast magnetic fields are generated, nor how these large-scale magnetic fields affect galaxy formation and evolution," says Kaczmarek. "The LMC and SMC are our nearest neighbours, so understanding how they evolve may help us understand how our Milky Way Galaxy will evolve." "Understanding the role that magnetic fields play in the evolution of galaxies and their environment is a fundamental question in astronomy that remains to be answered." The paper is one of a growing number of new results that are building a map of the Universe's magnetism. According to Prof. Bryan Gaensler, Director of the Dunlap Institute for Astronomy & Astrophysics, University of Toronto, and a co-author on the paper, "Not only are entire galaxies magnetic, but the faint delicate threads joining galaxies are magnetic, too. Everywhere we look in the sky, we find magnetism." The paper appeared in the Monthly Notices of the Royal Astronomical Society. Explore further: Giant magnetic fields in the universe More information: J. F. Kaczmarek et al. Detection of a Coherent Magnetic Field in the Magellanic Bridge through Faraday Rotation, Monthly Notices of the Royal Astronomical Society (2017). DOI: 10.1093/mnras/stx206 , On Arxiv: https://arxiv.org/abs/1701.05962
News Article | May 12, 2017
For the first time, astronomers have detected a magnetic field associated with the Magellanic Bridge, the filament of gas stretching 75 thousand light-years between the Milky Way Galaxy's nearest galactic neighbours: the Large and Small Magellanic Clouds (LMC and SMC, respectively). Visible in the southern night sky, the LMC and SMC are dwarf galaxies that orbit our home galaxy and lie at a distance of 160 and 200 thousand light-years from Earth respectively, "There were hints that this magnetic field might exist, but no one had observed it until now," says Jane Kaczmarek, a PhD student in the School of Physics, University of Sydney, and lead author of the paper describing the finding. Such cosmic magnetic fields can only be detected indirectly, and this detection was made by observing the radio signals from hundreds of very distant galaxies that lie beyond the LMC and SMC. The observations were made with the Australia Telescope Compact Array radio telescope at the Paul Wild Observatory in New South Wales, Australia. "The radio emission from the distant galaxies served as background 'flashlights' that shine through the Bridge," says Kaczmarek. "Its magnetic field then changes the polarization of the radio signal. How the polarized light is changed tells us about the intervening magnetic field." A radio signal, like a light wave, oscillates or vibrates in a single direction or plane; for example, waves on the surface of a pond move up and down. When a radio signal passes through a magnetic field, the plane is rotated. This phenomenon is known as Faraday Rotation and it allows astronomers to measure the strength and the polarity--or direction--of the field. The observation of the magnetic field, which is one millionth the strength of the Earth's, may provide insight into whether it was generated from within the Bridge after the structure formed, or was "ripped" from the dwarf galaxies when they interacted and formed the structure. "In general, we don't know how such vast magnetic fields are generated, nor how these large-scale magnetic fields affect galaxy formation and evolution," says Kaczmarek. "The LMC and SMC are our nearest neighbours, so understanding how they evolve may help us understand how our Milky Way Galaxy will evolve." "Understanding the role that magnetic fields play in the evolution of galaxies and their environment is a fundamental question in astronomy that remains to be answered." The paper is one of a growing number of new results that are building a map of the Universe's magnetism. According to Prof. Bryan Gaensler, Director of the Dunlap Institute for Astronomy & Astrophysics, University of Toronto, and a co-author on the paper, "Not only are entire galaxies magnetic, but the faint delicate threads joining galaxies are magnetic, too. Everywhere we look in the sky, we find magnetism." The paper appeared in the Monthly Notices of the Royal Astronomical Society. Reference: "Detection of a Coherent Magnetic Field in the Magellanic Bridge Through Faraday Rotation," 2017 May, Monthly Notices of the Royal Astronomical Society [http://dx.doi.org/10.1093/mnras/stx206, preprint: https://arxiv.org/abs/1701.05962]. Please follow SpaceRef on Twitter and Like us on Facebook.
News Article | May 9, 2017
— Market Highlights A solenoid valve is an electromechanically operated valve. The valve is controlled by an electric current through an inbuilt solenoid along with a plunger that acts as an actuator to control the valve. It is unidirectional and can only act to open the valve when an electrical signal makes it active. Therefore solenoid valves are particularly used to allow the flow when and as long as an electrical signal is sent to the valve. The solenoid valves can be operated using either of DC (Direct Current) or AC (Alternating Current) electrical signals. Solenoid valves are used to control and modulate the flow of liquids and gases. Global Solenoid Valve Market has been growing rapidly from the last couple of years and registered the CAGR of more than 4%. Currently this market has been valued at more than US $4 billion which is up surging rapidly with the increasing demand from industries like oil and gas, water and wastewaters, chemical and petrochemical among others, states the team Research Analyst while commenting upon this deep diving Market study report presented through more than 100 market data tables and figures spread over 145 pages. Key Players • Curtiss-Wright Corporation • Asco Valve • Inc. • Christian Bürkert GmbH & Co. Kg • GSR Ventiltechnik GmbH & Co. Kg • Danfoss A/S • Parker Hannifin Corporation • IMI PLC • Rotex Controls B.V. • The Lee Company • SMC Corporation Synopsis & Scenario The Global Solenoid Valve Market accounted for 4 Billion USD and is expected to grow remarkably in the years to come. The factors contributing to the market growth are - low power consumption, technology advancement, automotive flow system etc. The factors that hinder the market growth are the size of the equipment, level of customization of the equipment, and application in which the equipment is used. Solenoid Valves are becoming more popular these days as it can be controlled electronically and gives more effective and efficient result. Regional Analysis North America dominated the global market of solenoid Valves up to 2015 followed by Europe region. The main factor which is driving the market is increase in the demand for solenoid valve in various industries. North America holds the largest market share Asia Pacific has emerged as the fastest growing market accounting a significant market share with a considerable rate of CAGR. Market Segmentation The Global Solenoid Valve Market is segmented in to 4 Key Dynamics – By type, Body Material, Operating type and End user industries - for the forecasted period (2016 -2027) • Segmentation on the Basis of Type: Comprises - 2-way, 3-way, 4-way, and 5-way Solenoid Valves. • Segmentation on the Basis of Body Material: Comprising Brass Body, Stainless Steel, Aluminum Body and Plastic Body material. • Segmentation on the Basis of Operating Type: Comprising Direct, Indirect and semi-direct Operating type • Segmentation on the Basis of End user industries: Comprises Chemical & Petrochemical, Oil & Gas, Food & Beverages, Water & Wastewater, Power Generation, Automotive, Pharmaceutical, Medical and others. Taste the market data and market information presented through more than 85 market data tables and figures spread in 145 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Solenoid valve Market Research Report- Forecast to 2027" Brief TOC of Global Solenoid Valve Market 1 Executive Summary 2 Scope of the Report 2.1 Market Definition 2.2 Scope of the Study 2.3 Markets Structure 3 Market Research Methodology 3.1 Research Process 3.2 Secondary Research 3.3 Primary Research 3.4 Forecast Model 4 Market Landscape 5 Industry Overview of Global Solenoid valve Market 5.1 Introduction 5.2 Growth Drivers 5.3 Impact analysis 5.4 Market Challenges Continued…. Study Objective of Solenoid Valve market • To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global Solenoid valve market • To provide insights about factors affecting the market growth • To analyze the Solenoid valve market based on various factors- price analysis, supply chain analysis, porter’s five force analysis etc. • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World (ROW) • To provide country level analysis of the market with respect to the current market size and future prospective • To provide country level analysis of the market for segment by type, by body material, by operating type and sub-segments. • To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Solenoid valve market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. For more information, please visit https://www.marketresearchfuture.com/reports/solenoid-valve-market
News Article | September 25, 2017
FourKites, the leading end-to-end supply chain tracking and predictive analytics solution, announces its partnership with SMC³, the leading less-than-truckload (LTL) data and API solutions provider, enabling FourKites customers to track all of their freight with the highest accuracy, including the market’s most comprehensive LTL data. Real-time LTL load tracking enables FourKites customers to run their supply chains more efficiently based on more accurate location data. LTL tracking is critical to delivering end-to-end visibility but presents unique challenges because LTL loads often undergo a complex series of handoffs, including time spent at cross-docks and distribution centers. Determining load status at every point along that journey requires the industry’s best data. By partnering with SMC³, FourKites eliminates this difficulty and solves the challenge of providing accurate, real-time visibility for LTL shipments. “FourKites is a trusted SMC³ partner, and we’re pleased to join forces with an innovative and recognized leader in providing real-time supply chain visibility across all transportation modes,” said SMC³ President and CEO Andrew Slusher. “By selecting SMC³’s LTL APIs, FourKites is powering its platform with best-in-class freight APIs that optimize the complete LTL shipment lifecycle, solving the visibility needs of customers by providing reliable, secure solutions.” “FourKites is committed to bringing superior visibility to the entire global supply chain — all loads, all modes, all stops,” said Matt Elenjickal, CEO of FourKites. “Partnering with the industry leader in LTL ensures that we can continue to give our customers the best information available for this mode, allowing them to make powerful, informed decisions, and provide better customer service on loads that have traditionally been very difficult to track.” SMC³ is the one-stop knowledge hub for less than truckload technology, data and education. The API-powered SMC³ Platform delivers unrivaled LTL analytical capabilities and shipment visibility data. Best known for its trusted CzarLite®, RateWare® and CarrierConnect® rating and transit solutions, SMC3 also delivers industry leading direct-to-carrier LTL APIs. As the single integration point for all carrier rate, transit and service information, SMC³ solutions travel beyond simple connectivity and empower shippers, 3PLs and carriers to collaborate and optimize decision making throughout the entire LTL lifecycle -- from rating through the invoicing process. Thousands of industry trading partners rely on SMC³ solutions to make informed business decisions, achieve higher returns on their transportation investment, and meet ever-changing market demands. To learn more, visit http://www.smc3.com. FourKites is the real-time supply chain visibility platform that Fortune 500 companies and 3PLs trust to track shipment location and temperature, calculate ETAs and proactively manage exceptions. Using a proprietary predictive algorithm to calculate shipment arrival times, FourKites enables customers to lower their operating costs, improve on-time performance, and strengthen customer relationships. Using FourKites, shippers and 3PLs share the same, real-time shipping location and status information from more than four million GPS/ELD devices. FourKites tracks and consolidates data across modes – including ocean, rail, parcel, and over-the-road, with both truckload and less-than-truckload – into a unified platform built for global enterprise companies. The platform is optimized for mobile and equipped with market-leading end-to-end security. To learn more, visit http://www.fourkites.com.
News Article | September 21, 2017
James Welch, president and CEO of YRC Worldwide; Mathew Elenjickal, CEO of FourKites; Trent Broberg, general manager of Truckstop.com; and Michael Campese, vice president of Estes Express, are among the first supply chain experts booked to speak at SMC³’s Jump Start 2018 conference. The event will be held January 22-24 at the Loews Atlanta Hotel. To register, visit http://www.smc3jumpstart.com. Attendees who register for the conference during the month of September will benefit from early-bird pricing; SMC³ will also donate 10 percent of the registration fees collected during the month to the American Red Cross to support relief efforts surrounding hurricanes Irma and Harvey. Terry Jones, founder of Travelocity.com and the founding chairman of Kayak.com, will give the keynote address. Jones will discuss innovation, leadership and customer relationships with Jump Start attendees. Held each January in Atlanta, Jump Start focuses on the biggest topics that will impact the transportation marketplace in the coming year, touching virtually every aspect of today’s modern supply chain. Under this year’s theme of “Disruptors and Opportunities in a Year of Complexity,” attendees will dissect trends in API communications, explore pending regulations and their potential supply chain impacts, and learn about the latest trends in last-mile shipping, 3D printing and other game-changing business strategies. Jump Start 2018 brings together more than 40 industry experts for 20 engaging, targeted sessions that discuss and analyze the transportation topics making waves in today’s market. Attendees will also benefit from 17 hours of networking opportunities, including SMC³’s famous Ignite Speed Meetings, a reception held at the Mercedes Benz Stadium and an evening of world-class entertainment. “At SMC³, we craft our conference content to make sure attendees leave our events armed with the insights and knowledge needed to make informed business decisions,” said Andrew Slusher, SMC³ CEO and president. “Combine that with unrivaled networking opportunities, and it’s easy to see why Jump Start has become one of the preeminent supply chain conferences in North America.” SMC³ is a hub of expertise in the LTL arena. Fueled by heavyweight, analytical APIs, SMC³ delivers its core competency – LTL pricing expertise – through collaborative pricing technology that supports end-to-end, ongoing predictability in shipper/3PL-carrier relationships. More than 5,000 North American shippers, carriers, logistics service providers and freight-payment companies rely on SMC³’s sophisticated LTL base rates, content, and expert bidding and planning tools to make the best business decisions, achieve higher returns on their transportation investment, and meet the dynamic demands of the market. Through hosted API solutions, SMC³ supports the entire supply chain with industry-leading speed, reliability and performance. SMC³: Investing a lifetime to help optimize freight transportation.
News Article | September 19, 2017
SMC³ and its employees have donated a total of $30,000 to the American Red Cross, earmarked to assist recovery efforts associated with hurricanes Harvey and Irma. In one week, company employees raised a total of $6,000 for hurricane relief; SMC³ then doubled each dollar contributed by its employees and secured additional matching contributions. In addition to the $30,000 donation, SMC³ has announced it will donate 10 percent of each paid registration fee from Jump Start 2018, one of North America’s preeminent supply chain conferences, to the American Red Cross through the end of September. To learn more about the conference and to register, visit http://www.smc3jumpstart.com. On August 25, Hurricane Harvey made landfall in the Houston area as a Category 4 storm. Hurricane Irma followed when it hit Florida September 10 and 11, after causing devastation in the Caribbean. Relief efforts to bring aid to victims of both natural disasters will be stretched out for months and years to come. “Hurricanes Harvey and Irma uprooted families and disrupted many lives. Our employees immediately set about offering assistance to victims of these natural disasters,” said Andrew Slusher, SMC³ CEO and president. “Given the magnitude of the damage caused by these storms, I felt that SMC³ should amplify the charitable work done by our caring and compassionate team of professionals. We’re thankful that we can provide aid where and when it is needed so those affected by the storms can get back on their feet.” SMC³ has a longstanding commitment to humanitarian efforts. Much of this occurs in the immediate community, but when a disaster strikes, the company strives to help out in any way possible. During initial recovery efforts for the hurricanes, employees were engaged locally in sending relief supplies to Houston and the surrounding area. SMC³ has also been a longtime sponsor of local charities and arts organizations. SMC³ is the leading provider of data, technology and education as an integrated solution to the freight transportation community. SMC³ delivers its core competency – LTL pricing expertise – through collaborative pricing technology that supports end-to-end, ongoing predictability in shipper/3PL-carrier relationships. Best known for its CzarLite®, Bid$ense® and RateWare® solutions, the company serves more than 5,000 customers throughout North America, including shippers, carriers, logistics service providers and freight-payment companies. SMC³ also partners with leading transportation software developers for complete interoperability.